FH and hereditary leiomyomatosis and renal cell cancer: This comprehensive and integrated proteogenomic analysis of ULM tissues from an exceptionally rare cohort of HLRCC patients provides a comprehensive view into the impact of FH mutation-driven alterations on the transcriptome and proteome in this high-risk population.